Table 1.
Clinical and pathological variable | GSE14520 (n = 190) | GSE76427 (n = 100) |
---|---|---|
Gender (male/female) | 161/29 | 79/21 |
Age (years) | 51.22 ± 10.75 | 63.32 ± 12.8 |
AVR-CC (no/yes/NA) | 132/53/5 | NA |
ALT (<=50 U/l/>50 U/l) | 117/73 | NA |
Main tumor size (<=5 cm/>5 cm/NA) | 133/56/1 | NA |
Multinodular (no/yes) | 157/33 | NA |
Cirrhosis (no/yes) | 16/174 | NA |
TNM stage (I-II/III-IV/NA) | 168/22/0 | 85/14/1 |
CLIP stage(0/1/2/3) | 94/70/25/1 | NA |
BCLC stage (0/A/B) | 20/148/22 | 4/71/25 |
AFP (<=300 ng/ml/>300 ng/ml/NA) | 108/79/3 | NA |
Abbreviations: AVR-CC: active viral replication chronic carrier; ALT: alanine aminotransferase; TNM: tumor node metastasis; CLIP: cancer liver Italian program; BCLC: Barcelona Clinic Liver Cancer; AFP: alpha-fetoprotein.